SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Georgia O'Keeffe — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientGeorgia O'Keeffe
Date of birth1887-11-15
IdentifiersMRN HR-ET011-SYN-TD; SSN (made up) 000-11-5873
Document date1968-03-12
AuthorWendell Ashby, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Retina evaluation of new distortion and blur in the left eye. [S]

History of Present Illness

Ms. O'Keeffe is seen in the retina clinic two days after her primary care visit, where new distortion and a blurred central spot in the left eye were found on the Amsler grid. Over the past few weeks straight lines on her canvases and door frames have looked bent with the left eye, and small print and fine color differences have become hard to judge. The right eye seems unchanged. She has had no eye pain, redness, flashes, or new floaters. She takes no blood thinners and no other medicines. She paints daily and is afraid of losing the central vision she needs for her work. [S]

ElementDetail
OnsetOver the past few weeks
SymptomsBent lines and a central blurred spot, left eye; trouble with small print and fine color differences
Fellow eyeNo change noticed in the right eye
Pertinent negativesNo pain, redness, flashes, or new floaters
MedicinesNone; no anticoagulants
Patient concernKeeping the central vision she needs to paint

Review of Systems

SystemResultFinding
EyesPositiveDistortion and a central blurred spot in the left eye; no pain, redness, flashes, or floaters
ConstitutionalNegativeNo weight loss or fatigue
NeurologicalNegativeNo headache, double vision, or weakness
PsychiatricPositiveWorried about losing the vision she needs to paint; mood otherwise steady

4 systems reviewed. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1968-03-12Body height165cmS
1968-03-12Body weight56kgS
1968-03-12Body mass index (BMI) [Ratio]20.6kg/m2S
1968-03-12Systolic blood pressure130mm[Hg]S
1968-03-12Diastolic blood pressure72mm[Hg]S
1968-03-12Heart rate72/minS
1968-03-12Respiratory rate14/minS
1968-03-12Body temperature36.5CelS
1968-03-12Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1968-03-12Visual acuity best corrected Right eye by ETDRS eye chart78{letters}>=80LowS
1968-03-12Visual acuity best corrected Left eye by ETDRS eye chart55{letters}>=80LowS
1968-03-12Macular grid.center subfield thickness by OCT418um200-300 umHighS
1968-03-12Right eye Intraocular pressure15mm[Hg]10-21 mmHgNormalS
1968-03-12Left eye Intraocular pressure16mm[Hg]10-21 mmHgNormalS

Physical Exam

Vital signs recorded on 1968-03-12; see the Vital Signs section. [S]

SystemFinding
Visual acuityBest-corrected 78 letters right and 55 letters left
Intraocular pressure15 mmHg right and 16 mmHg left before injection
Anterior segmentQuiet in both eyes
Dilated fundus, left eyeGray-green subretinal lesion under the fovea with surrounding fluid; large drusen
Dilated fundus, right eyeLarge drusen and pigment changes; no fluid or hemorrhage
OCTLeft eye: subretinal fluid, central subfield thickness 418 µm. Both eyes: large drusen
After injection, left eyeOptic nerve head perfused; counts fingers; no pain

Problems

ProblemClinical statusVerificationCodeProvenance
Neovascular (wet) age-related macular degeneration, left eye, with active choroidal neovascularizationactiveconfirmed H35.3221S — Synthetic modern diagnosis linked to her documented failing eyesight; the historical type of macular degeneration is not recorded.
Nonexudative age-related macular degeneration, right eye, intermediate stageactiveconfirmed H35.3112S — Synthetic finding in the fellow eye.
New distortion (wavy lines) and a blurred central spot with reduced acuity in the left eye; suspected neovascular macular degeneration, urgent retina referralresolvedconfirmed H53.15S — Synthetic presenting concern at the index visit, superseded by the OCT diagnosis at the retina consultation; her failing eyesight is documented (D).

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBest-corrected visual acuity (ETDRS letters)Every injection visitCompleted todayBaseline before treatment: 78 letters right, 55 letters left
ImagingOptical coherence tomography of the maculaEvery injection visitCompleted todayBoth eyes. Left: subretinal fluid, central subfield thickness 418 µm. Both: large drusen
ImagingFluorescein angiography or OCT angiographyAt diagnosis of suspected neovascular AMDDeferredNot performed. OCT and fundus findings were typical, so treatment began the same day without angiography, a departure from the PPP's diagnostic recommendation. Angiography will be done if the response to loading is poor or the picture becomes atypical
ExaminationIntraocular pressure before and after injectionEvery injection visitCompleted todayBefore injection 15 mmHg right and 16 mmHg left. After injection the check was by optic nerve perfusion and counting fingers rather than a second pressure reading
ExaminationComprehensive dilated eye examinationEvery 1 to 2 years at 65 or olderCompleted todayAcuity, pressure, slit-lamp, and dilated fundus examination of both eyes today
ExaminationDilated examination of the fellow (right) eyeEvery injection visitCompleted todayLarge drusen; no fluid or hemorrhage
Medication safetyIntravitreal injection safetyEvery injection visitCompleted todayPovidone-iodine preparation; no complication; first loading dose
Self-managementTeaching on warning signs of endophthalmitis and retinal detachmentEvery injection visitCompleted todayTaught today with written instructions in large print
Self-managementDaily home Amsler grid, each eyeDailyCompleted todayReviewed her technique with each eye covered in turn
Medication safetyAREDS2 supplement for intermediate AMDDaily, long termCompleted todayStarted today; the formula without beta-carotene
SurveyFunctional vision assessment (reading, color, driving, work)At diagnosis; again with changeCompleted todayTrouble with small print and fine color judgment; drives short routes by day
ReferralLow-vision rehabilitation, with home fall-risk review and a driving assessmentOnce central vision is reduced; review as vision changesReferredReferral sent today
SurveyDepression screen (PHQ-2)At follow-up, because vision loss raises the risk of depression; periodically at 65 or olderDueScore 1 two days ago; repeat at the July primary care review

Goal progress:

Guideline basis: Age-Related Macular Degeneration Preferred Practice Pattern (2024); CMID: Clinical Monitoring Intelligence Database, cataract and glaucoma monographs (eye-examination items) (2026)

Follow-up: Retina visit in four weeks for acuity, OCT, pressure, and the second injection. Same-day call for warning signs or new distortion in either eye. Next scheduled visit 1968-04-09: four-week retina follow-up with OCT and second injection. [S]